As Passed by the Senate

135th General Assembly

Regular Session Sub. S. B. No. 95

2023-2024

Senator Reynolds

Cosponsors: Senators Huffman, S., Antonio, Blessing, Brenner, Chavez, Cirino, Craig, DeMora, Dolan, Gavarone, Hackett, Hicks-Hudson, Ingram, Johnson, Kunze, Landis, Manning, Reineke, Roegner, Romanchuk, Schaffer, Schuring, Sykes, Wilkin, Wilson


A BILL

To amend sections 4729.285, 4729.45, and 4729.921 and to enact sections 3959.22 and 4729.554 of the Revised Code related to remote dispensing pharmacies and other changes to the pharmacy law.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That sections 4729.285, 4729.45, and 4729.921 be amended and sections 3959.22 and 4729.554 of the Revised Code be enacted to read as follows:

Sec. 3959.22. No health plan issuer, pharmacy benefit manager, or any other administrator shall prohibit a pharmacy from mailing or delivering drugs to patients as an ancillary service.

Sec. 4729.285. A pharmacist may provide telehealth services in accordance with section 4743.09 of the Revised Code, except that in the case of dispensing a dangerous drug, a pharmacist shall not use telehealth mechanisms or other virtual means to perform any of the actions involved in dispensing the dangerous drug unless the action is authorized by section 4729.554 of the Revised Code or by the state board of pharmacy through rules it adopts under this chapter or section 4743.09 of the Revised Code.

Sec. 4729.45. (A) As used in this section, "physician" means an individual authorized under Chapter 4731. of the Revised Code to practice medicine and surgery or osteopathic medicine and surgery.

(B)(1) Subject to division (C) of this section, a pharmacist licensed under this chapter may administer by injection any of the following drugs as long as the drug that is to be administered has been prescribed by a physician and the individual to whom the drug was prescribed has an ongoing physician-patient relationship with the physician:

(a) An addiction treatment drug administered in a long-acting or extended-release form;

(b) An antipsychotic drug administered in a long-acting or extended-release form;

(c) A human immunodeficiency virus treatment drug administered in a long-acting or extended-release form;

(d) Hydroxyprogesterone caproate;

(d) (e) Medroxyprogesterone acetate;

(e) (f) Cobalamin;

(g) Any other drug that is specified in rules adopted under division (H)(2) of this section.

(2) As part of engaging in the administration of drugs by injection pursuant to this section, a pharmacist may administer epinephrine or diphenhydramine, or both, to an individual in an emergency situation resulting from an adverse reaction to a drug administered by the pharmacist.

(C) To be authorized to administer drugs pursuant to this section, a pharmacist must do all of the following:

(1) Successfully complete a course in the administration of drugs that satisfies the requirements established by the state board of pharmacy in rules adopted under division (H)(1)(a) of this section;

(2) Receive and maintain certification to perform basic life-support procedures by successfully completing a basic life-support training course that is certified by the American red cross or American heart association or approved by the state board of pharmacy;

(3) Practice in accordance with a protocol that meets the requirements of division (F) of this section.

(D) Each time a pharmacist administers a drug pursuant to this section, the pharmacist shall do all of the following:

(1) Obtain permission in accordance with the procedures specified in rules adopted under division (H) of this section and comply with the following requirements:

(a) Except as provided in division (D)(1)(c) of this section, for each drug administered by a pharmacist to an individual who is eighteen years of age or older, the pharmacist shall obtain permission from the individual.

(b) For each drug administered by a pharmacist to an individual who is under eighteen years of age, the pharmacist shall obtain permission from the individual's parent or other person having care or charge of the individual.

(c) For each drug administered by a pharmacist to an individual who lacks the capacity to make informed health care decisions, the pharmacist shall obtain permission from the person authorized to make such decisions on the individual's behalf.

(2) In the case of an addiction treatment drug described in division (B)(1)(a) of this section, obtain in accordance with division (E) of this section test results indicating that it is appropriate to administer the drug to the individual if either of the following is to be administered:

(a) The initial dose of the drug;

(b) Any subsequent dose, if the administration occurs more than thirty days after the previous dose of the drug was administered.

(3) Observe the individual to whom the drug is administered to determine whether the individual has an adverse reaction to the drug;

(4) Notify the physician who prescribed the drug that the drug has been administered to the individual.

(E) A pharmacist may obtain the test results described in division (D)(2) of this section in either of the following ways:

(1) From the physician who prescribed the drug;

(2) By ordering blood and urine tests for the individual to whom the drug is to be administered.

If a pharmacist orders blood and urine tests, the pharmacist shall evaluate the results of the tests to determine whether they indicate that it is appropriate to administer the drug. A pharmacist's authority to evaluate test results under this division does not authorize the pharmacist to make a diagnosis.

(F) All of the following apply with respect to the protocol required by division (C)(3) of this section:

(1) The protocol must be established by a physician who has a scope of practice that includes treatment of the condition for which the individual has been prescribed the drug to be administered.

(2) The protocol must satisfy the requirements established in rules adopted under division (H)(1)(b) of this section.

(3) The protocol must do all of the following:

(a) Specify a definitive set of treatment guidelines;

(b) Specify the locations at which a pharmacist may engage in the administration of drugs pursuant to this section;

(c) Include provisions for implementing the requirements of division (D) of this section, including for purposes of division (D)(3) of this section provisions specifying the length of time and location at which a pharmacist must observe an individual who receives a drug to determine whether the individual has an adverse reaction to the drug;

(d) Specify procedures to be followed by a pharmacist when administering epinephrine, or diphenhydramine, or both, to an individual who has an adverse reaction to a drug administered by the pharmacist.

(G) A pharmacist shall not do either of the following:

(1) Engage in the administration of drugs pursuant to this section unless the requirements of division (C) of this section have been met;

(2) Delegate to any person the pharmacist's authority to engage in the administration of drugs pursuant to this section.

(H)(1) The (H) With respect to the adoption of rules by the state board of pharmacy shall adopt rules to implement this section. The rules shall be adopted in accordance with Chapter 119. of the Revised Code and , all of the following apply:

(1) The board shall adopt rules that include all of the following:

(a) Requirements for courses in administration of drugs;

(b) Requirements for protocols to be followed by pharmacists in administering drugs pursuant to this section;

(c) Procedures to be followed by a pharmacist in obtaining permission to administer a drug to an individual.

(2) The board may adopt rules that specify other drugs, as provided in division (B)(1)(g) of this section, that a pharmacist may administer by injection in accordance with this section.

(3) The board shall consult with the state medical board before adopting rules regarding requirements for protocols under divisions (H)(1)(b) and (2) of this section.

(4) All rules shall be adopted in accordance with Chapter 119. of the Revised Code.

Sec. 4729.554. (A) As used in this section:

(1) "Remote dispensing pharmacy" means a pharmacy where the dispensing of drugs, patient counseling, and other pharmacist care is provided through a telepharmacy system. The dispensing of drugs at a remote dispensing pharmacy may include the dispensing of drug therapy related devices.

(2) "Telepharmacy system" means a system that monitors the dispensing of drugs and provides for related drug utilization review and patient counseling services by an electronic method.

(B) The state board of pharmacy shall regulate remote dispensing pharmacies in accordance with this section. A remote dispensing pharmacy may operate only by using a telepharmacy system that meets standards established in rules adopted under this section and by complying with all other requirements of this section and the rules adopted under it for operating a remote dispensing pharmacy.

(C)(1) To be eligible to operate as a remote dispensing pharmacy, a pharmacy shall meet all of the following conditions:

(a) Be licensed under this chapter as a terminal distributor of dangerous drugs;

(b) Be located in this state, in a building that is zoned for commercial use, and in an area that meets the conditions of division (C)(2) of this section;

(c) Have a supervising pharmacy that meets the requirements of division (D) of this section and a supervising pharmacist that meets the requirements of division (E) of this section;

(d) Be staffed by two or more pharmacy interns or certified pharmacy technicians who meet qualifications and training requirements established in rules adopted under this section.

(2)(a) Except as provided in division (C)(2)(b) of this section, a remote dispensing pharmacy shall not be located within a ten-mile radius of a pharmacy that serves the public as an outpatient pharmacy.

(b) A remote dispensing pharmacy may be located within the ten-mile radius that constitutes an excluded area for location, as described in division (C)(2)(a) of this section, if either of the following is the case:

(i) The remote dispensing pharmacy is part of a federally qualified health center or federally qualified health center look-alike, as defined in section 3701.047 of the Revised Code, and the remote dispensing pharmacy is located on the same property as, or on a campus contiguous to, the health center or look-alike.

(ii) The board, based on a demonstration of need that meets the standards established in rules adopted under this section, approves a request submitted to the board to allow the remote dispensing pharmacy to be located within the ten-mile radius.

(c) As part of the process the board uses to consider requests received under division (C)(2)(b)(ii) of this section, the board shall establish a method by which persons may register to receive notice from the board of requests received under that division. The board also shall establish a system for accepting comments from the public regarding the requests.

When the board receives a request under division (C)(2)(b)(ii) of this section, it shall electronically notify any person who has registered to be notified. During the sixty-day period that begins on the date that the board sends the electronic notices, a pharmacy may submit a request to the board for approval as a location for operation of a remote dispensing pharmacy.

On the same date that the electronic notices are sent, the board shall post notice on its internet web site that comments from the public will be accepted regarding the request received under division (C)(2)(b)(ii) of this section. The board shall accept the comments only during the sixty-day period that begins on the date the electronic notices are sent.

At the board's next regularly scheduled meeting that occurs on or after the date that is ninety days after the electronic notices are sent, the board shall review all of the requests received and make its determination of whether any should be approved. As part of the board's determination, the board shall consider the following:

(i) Any comments received from the public;

(ii) The geographic proximity of a supervising pharmacy to a proposed remote dispensing pharmacy;

(iii) Any other standards specified in rules adopted under division (H) of this section.

(D)(1) To be eligible to serve as the supervising pharmacy of a remote dispensing pharmacy, a pharmacy shall meet all of the following conditions:

(a) Be licensed under this chapter as a terminal distributor of dangerous drugs;

(b) Be physically located in this state;

(c) Be under common ownership and control with the remote dispensing pharmacy or, pursuant to a contract that meets requirements specified in rules adopted under this section, operate under contract with the remote dispensing pharmacy.

(2) In serving as a supervising pharmacy, the supervising pharmacy shall control the telepharmacy system used by the remote dispensing pharmacy and shall employ or contract with the supervising pharmacist of the remote dispensing pharmacy.

(E)(1) To be eligible to serve as the supervising pharmacist of a remote dispensing pharmacy, a pharmacist shall meet all of the following conditions:

(a) Be licensed under this chapter as a pharmacist;

(b) Be physically located in this state when acting as the supervising pharmacist;

(c) Be employed by or under contract with the supervising pharmacy.

(2) In serving as a supervising pharmacist, the supervising pharmacist shall do all of the following:

(a) Be in full and actual charge of the remote dispensing pharmacy by using the the pharmacy's telepharmacy system and by using a surveillance system that meets standards established in rules adopted under this section;

(b) Through the telepharmacy system and surveillance system, oversee the pharmacy interns and certified pharmacy technicians who are staffing the remote dispensing pharmacy;

(c) Verify each prescription and drug dispensed pursuant to the prescription before the drug leaves the remote dispensing pharmacy and provide the verification through visual review and the use of barcoding and any other technology required in rules adopted under this section;

(d) Offer to provide the service of counseling for each drug dispensed pursuant to a new prescription for a patient at the remote dispensing pharmacy.

(3) Unless otherwise approved by the board in accordance with standards established in rules adopted under this section, a supervising pharmacist shall not simultaneously oversee the activities of more than one remote dispensing pharmacy.

(F) All of the following apply to the operation of a remote dispensing pharmacy:

(1) Unless otherwise approved by the board, a remote dispensing pharmacy shall not dispense drugs pursuant to more than an average of one hundred fifty prescriptions per day during a ninety-day period.

(2) A remote dispensing pharmacy shall implement a quality assurance plan to ensure that there is a planned and systematic process for monitoring and evaluating the quality and appropriateness of the pharmacy services being provided and for identifying and resolving problems.

(3) A remote dispensing pharmacy that holds a category III terminal distributor of dangerous drugs license shall maintain a perpetual controlled substance inventory, as specified in rules adopted under this section.

(G) Notwithstanding section 4729.91 of the Revised Code or any other section of this chapter to the contrary, both of the following apply to a pharmacy intern or certified pharmacy technician staffing a remote dispensing pharmacy:

(1) The intern or technician may assist in the process of dispensing drugs at the pharmacy.

(2) The intern or technician shall not do any of the following:

(a) Counsel an individual regarding drugs that are dispensed, recommend drugs and drug therapy related devices or otherwise provide advice regarding drug therapy, or assist with selecting drugs and drug therapy related devices for treatment of common diseases and injuries or assist with providing instruction on their use;

(b) Perform compounding of sterile or nonsterile drugs, except for the reconstitution of prepackaged dangerous drugs;

(c) Engage in the repackaging of dangerous drugs;

(d) Administer immunizations or perform diagnostic testing, unless a pharmacist is onsite to provide direct supervision;

(e) Perform any other activity prohibited by rules adopted under this section.

(H) The board shall adopt rules for purposes of its regulation of remote dispensing pharmacies. The rules shall be adopted in accordance with Chapter 119. of the Revised Code and include all of the following:

(1) Standards for a system of continuous video surveillance and recording of remote dispensing pharmacies, including standards for both of the following:

(a) An adequate number of views of the entire remote dispensing pharmacy to ensure that the supervising pharmacist can maintain oversight;

(b) Retention of each recording made by the system for at least sixty days after the date of the recording.

(2) Standards for telepharmacy systems and surveillance systems used by remote dispensing pharmacies, supervising pharmacies, and supervising pharmacists, including standards to ensure that the systems are capable of all of the following:

(a) Facilitating a safe and secured method for appropriate pharmacist supervision;

(b) Allowing an appropriate exchange of visual, verbal, and written communications for patient counseling and other pharmacy services;

(c) Being secure and compliant with the "Health Insurance Portability and Accountability Act of 1996," 42 U.S.C. 1320d et seq.

(3) Requirements for any contract between a supervising pharmacy and a remote dispensing pharmacy;

(4) Standards that must be met to make a demonstration of need for purposes of division (C)(2)(b)(ii) of this section;

(5) Requirements for the implementation of a quality assurance plan by a remote dispensing pharmacy;

(6) The qualifications and training necessary for pharmacy interns and certified pharmacy technicians who staff remote dispensing pharmacies, including the number of experiential hours required;

(7) Any additional activities that pharmacy interns and certified pharmacy technicians staffing remote dispensing pharmacies are prohibited from performing;

(8) The number of pharmacy interns and certified pharmacy technicians that a supervising pharmacist may supervise at any given time;

(9) The maximum distance a supervising pharmacist may be physically located from the remote dispensing pharmacy;

(10) Standards for remote patient counseling by a supervising pharmacist, including the counseling that is required to be offered for each drug dispensed pursuant to a new prescription for a patient by the remote dispensing pharmacy;

(11) Standards for and frequency of inspection of a remote dispensing pharmacy by the supervising pharmacist;

(12) Requirements for the closure of a remote dispensing pharmacy if the required telepharmacy system or surveillance system, or any related security system used by or for the pharmacy, is malfunctioning;

(13) Requirements related to perpetual controlled substance inventories;

(14) Security requirements for remote dispensing pharmacies that include methods for supervising pharmacists to determine who has accessed the pharmacy;

(15) Standards by which a supervising pharmacist may be approved by the board to oversee simultaneously more than one remote dispensing pharmacy;

(16) Requirements for a remote dispensing pharmacy's responsible person, as that term is defined in rules adopted by the board;

(17) Any other standards or procedures the board considers necessary to implement this section.

Sec. 4729.921. (A) An applicant for registration as a pharmacy technician trainee shall file with the state board of pharmacy an application in the form and manner prescribed in rules adopted under section 4729.94 of the Revised Code. The application shall by accompanied by an application fee of twenty-five dollars, which shall not be returned if the applicant fails to qualify for registration.

If the board is satisfied that an applicant meets the requirements of section 4729.92 of the Revised Code and any additional requirements established by the board and determines that the results of a criminal records check do not make the applicant ineligible, the board shall register the applicant as a pharmacy technician trainee.

(B)(1) The board shall register as a pharmacy technician trainee in accordance with Chapter 4796. of the Revised Code an applicant who either holds a license or is registered in another state or has satisfactory work experience, a government certification, or a private certification as described in that chapter as a pharmacy technician trainee in a state that does not issue that license or registration.

(2) The board may register as a pharmacy technician trainee an applicant who is seventeen years of age and if either of the following apply:

(a) The applicant possesses a high school diploma or certificate of high school equivalence;

(b) The applicant does not possess a high school diploma or certificate of high school equivalence if the applicant but is enrolled in a career-technical school program that is approved by the board and conducted by a city, exempted village, local, or joint vocational school district.

(C) The board shall not refuse to register an applicant as a pharmacy technician trainee because of a conviction for an offense unless the refusal is in accordance with section 9.79 of the Revised Code.

(D) Registration is valid for one year from the date of registration, except that the board may extend the time period for which registration is valid. Registration is not renewable, but an individual may reapply for registration if the individual's previous registration has lapsed for more than five years or the board grants its approval.

Section 2. That existing sections 4729.285, 4729.45, and 4729.921 of the Revised Code are hereby repealed.

Section 3. The State Board of Pharmacy shall adopt the rules required by section 4729.554 of the Revised Code not later than eighteen months after the effective date of this section. If the Board fails to adopt the rules within that time period, the Attorney General or a county prosecuting attorney may apply to a court of common pleas for a court order requiring the adoption of the rules.